Xenous Holdings, Inc. reported a leadership change in which Jonathan Chan resigned as Chief Executive Officer and Director, effective May 8, 2026. The company states his resignation was not due to any disagreement over operations, policies, or practices.
On the same day, the Board appointed Dingwen Zhang as Executive Officer and Director, filling the vacancy. Zhang has founded and led several firms, including Soon Fund and Beishang Capital, and holds a Bachelor of Finance from Tsinghua University. He currently has no employment agreement or compensation arrangements with Xenous and no disclosed related-party transactions.
Xenous Holdings, Inc. remains a development-stage shell with no operations, no assets and no cash as of December 31, 2025. Total liabilities were $950,127, all current, resulting in an equal stockholders’ deficit and working capital deficit.
The company reported a net loss of $15,519 for the quarter and $46,505 for the nine months ended December 31, 2025, similar to the prior year and driven mainly by professional and administrative fees. Accumulated deficit reached $1,260,927.
Operations are financed entirely through non‑interest‑bearing, on‑demand advances from its controlling shareholder, with $926,283 due to Ms. Tan Lee San as of December 31, 2025. Management and auditors highlight substantial doubt about the company’s ability to continue as a going concern.
The stated strategy is to identify and acquire an operating business, with ongoing due diligence on a Malaysia-based Aquilaria-focused agriculture company expected to conclude in the second half of calendar 2026.
Xenous Holdings, Inc. submitted a Form 12b-25 notifying the SEC that it could not complete and file its Quarterly Report on Form 10-Q for the period ended December 31, 2025 without unreasonable effort and expense.
The notice is signed by Jonathan Chan Ye Earn, Chief Executive Officer, dated February 18, 2026. The filing states contact information as 852-3923-1188.
Xenous Holdings, Inc. (XITO) filed its quarterly report for the period ended September 30, 2025, showing it remains a non‑operating shell company with ongoing losses and a significant capital deficit. The company reported a net loss of $30,986 for the six months ended September 30, 2025, similar to the $31,155 loss a year earlier, and has accumulated deficit of $1,245,408.
Xenous reported no assets or cash, while current liabilities reached $934,608, resulting in a stockholders’ deficit and a working capital deficit of the same amount. Operations are funded entirely through related‑party advances; during the six‑month period, $31,445 was advanced, and the total due to the new controlling shareholder, Ms. Tan Lee San, was $911,163 as of September 30, 2025. The company’s auditors and management highlight substantial doubt about its ability to continue as a going concern, though management is pursuing a potential acquisition of a Malaysia‑based agricultural business and continuing due diligence.
Xenous Holdings, Inc. filed a Form 12b-25 to notify that its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025 will be filed late. The company states it was unable to meet the original deadline without unreasonable effort or expense because it needs additional time to complete and finalize the financial statements for that quarter.
The company indicates that it expects to file the Form 10-Q as soon as possible, signaling that the delay is intended to be temporary while the reporting process is finished.